HOUSE DOCKET, NO. 2060        FILED ON: 1/19/2017

HOUSE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No. 529

 

The Commonwealth of Massachusetts

_________________

PRESENTED BY:

Sean Garballey

_________________

To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:

The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:

An Act promoting continuity of care for multiple sclerosis treatment.

_______________

PETITION OF:

 

Name:

District/Address:

Date Added:

Sean Garballey

23rd Middlesex

1/19/2017

Patricia A. Haddad

5th Bristol

 

Paul J. Donato

35th Middlesex

 

Brendan P. Crighton

Third Essex

 

Daniel Cahill

10th Essex

 

John C. Velis

4th Hampden

1/24/2017

Paul Tucker

7th Essex

 

Claire D. Cronin

11th Plymouth

 

Paul McMurtry

11th Norfolk

 

Michael J. Finn

6th Hampden

 

David M. Nangle

17th Middlesex

 

Kimberly N. Ferguson

1st Worcester

 

William N. Brownsberger

Second Suffolk and Middlesex

1/27/2017

Joseph D. McKenna

18th Worcester

 

John H. Rogers

12th Norfolk

 

Sal N. DiDomenico

Middlesex and Suffolk

 

Brian M. Ashe

2nd Hampden

 

Timothy R. Whelan

1st Barnstable

 

James M. Cantwell

4th Plymouth

 

James J. Dwyer

30th Middlesex

 

Frank I. Smizik

15th Norfolk

 

Danielle W. Gregoire

4th Middlesex

 

James J. O'Day

14th Worcester

 

Thomas P. Walsh

12th Essex

 

Kenneth I. Gordon

21st Middlesex

 

Marc T. Lombardo

22nd Middlesex

 

David M. Rogers

24th Middlesex

 

Steven Ultrino

33rd Middlesex

 

David Paul Linsky

5th Middlesex

 

Denise Provost

27th Middlesex

 

Michael J. Barrett

Third Middlesex

 

Mary S. Keefe

15th Worcester

 

James R. Miceli

19th Middlesex

 

Kevin J. Kuros

8th Worcester

 

Jeffrey N. Roy

10th Norfolk

 

Michael S. Day

31st Middlesex

 

Jack Lewis

7th Middlesex

 

Carole A. Fiola

6th Bristol

 

Josh S. Cutler

6th Plymouth

 

Marjorie C. Decker

25th Middlesex

 

Jay D. Livingstone

8th Suffolk

 

Edward F. Coppinger

10th Suffolk

 

Evandro C. Carvalho

5th Suffolk

 

Hannah Kane

11th Worcester

 

John W. Scibak

2nd Hampshire

 

Jason M. Lewis

Fifth Middlesex

 

Thomas M. Stanley

9th Middlesex

 

Kay Khan

11th Middlesex

 

Carmine L. Gentile

13th Middlesex

 

Jonathan Hecht

29th Middlesex

 

Susannah M. Whipps

2nd Franklin

 

Daniel M. Donahue

16th Worcester

 

Ruth B. Balser

12th Middlesex

 

Donald F. Humason, Jr.

Second Hampden and Hampshire

 

Mike Connolly

26th Middlesex

 

Denise C. Garlick

13th Norfolk

 

Keiko M. Orrall

12th Bristol

 

Natalie Higgins

4th Worcester

 

James Arciero

2nd Middlesex

 

Diana DiZoglio

14th Essex

 

Antonio F. D. Cabral

13th Bristol

 

Kevin G. Honan

17th Suffolk

 

Bruce J. Ayers

1st Norfolk

 

Paul A. Schmid, III

8th Bristol

 

Angelo L. D'Emilia

8th Plymouth

 

Michelle M. DuBois

10th Plymouth

 

Tackey Chan

2nd Norfolk

 

Russell E. Holmes

6th Suffolk

 

Nick Collins

4th Suffolk

 

Daniel J. Hunt

13th Suffolk

 

James E. Timilty

Bristol and Norfolk

 


HOUSE DOCKET, NO. 2060        FILED ON: 1/19/2017

HOUSE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No. 529

By Mr. Garballey of Arlington, a petition (accompanied by bill, House, No. 529) of Sean Garballey and others relative to health insurance benefits for multiple sclerosis treatment.  Financial Services.

 

The Commonwealth of Massachusetts

 

_______________

In the One Hundred and Ninetieth General Court
(2017-2018)

_______________

 

An Act promoting continuity of care for multiple sclerosis treatment.

 

Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority of the same, as follows:
 

SECTION 1. Chapter 32A of the General Laws, as appearing in the 2014 Official Edition, is hereby amended by adding the following new section:-

Section 28. The commission shall provide to any active or retired employee of the commonwealth and who is insured under the group insurance commission coverage for a disease modifying prescription drug for treatment of multiple sclerosis that the individual has already been prescribed and has already been taking.  This section shall also require coverage for such an ongoing disease-modifying prescription drug treatment under any non-group policy.

SECTION 2. Chapter 175 of the General Laws, as appearing in the 2014 Official Edition, is hereby amended by inserting after Section 47GG the following new section:-

Section 47HH. Any policy of accident and sickness insurance as described in section 108 that provides hospital expense and surgical expense insurance and that is delivered, issued or subsequently renewed by agreement between the insurer and policyholder in the commonwealth; any blanket or general policy of insurance described in subdivision (A), (C) or (D) of section 110 that provides hospital expense and surgical expense insurance and that is delivered, issued or subsequently renewed by agreement between the insurer and the policyholder, within or without the commonwealth; or any employees’ health and welfare fund that provides hospital expense and surgical expense benefits and that is delivered, issued or renewed to any person or group of persons in the commonwealth, shall provide to a commonwealth resident covered by the policy, coverage for a disease-modifying prescription drug to treat multiple sclerosis that the individual has already been prescribed and has already been taking.  The benefits in this section shall not be subject to any greater deductible, coinsurance, copayments or out-of-pocket limits than any other disease-modifying prescription drug for multiple sclerosis provided by the insurer.  This section shall also require coverage for such an ongoing disease-modifying prescription drug treatment for multiple sclerosis under any non-group policy.

SECTION 3. Chapter 176A of the General Laws, as appearing in the 2014 Official Edition, is hereby amended by inserting after Section 8II the following new section:-

Section 8JJ. Any contract between a subscriber and the corporation under an individual or group  hospital service plan that is delivered, issued or renewed in the commonwealth shall provide as  benefits to any individual subscribers or members within the commonwealth a disease-modifying  prescription drug to treat multiple sclerosis that the individual has already been prescribed and has already been taking.  The benefits in this section shall not be subject to greater deductible, coinsurance, copayments or out-of-pocket limits than any other benefits for disease-modifying prescription drugs for multiple sclerosis provided by the insurer.  This section shall also require coverage for such an ongoing disease-modifying prescription drug treatment for multiple sclerosis under any non-group policy.

SECTION 4. Chapter 176B of the General Laws, as appearing in the 2014 Official Edition, is hereby amended by inserting after Section 4II the following new section:-

Section 4JJ. Any subscription certificate under an individual or group medical service agreement that shall be delivered, issued or renewed within the commonwealth shall provide as benefits to any individual subscriber or member within the commonwealth coverage for a disease-modifying prescription drug to treat multiple sclerosis that the individual has already been prescribed and has already been taking.  The benefits in this section shall not be subject to any greater deductible, coinsurance, copayments or out-of-pocket limits than any other disease-modifying prescription drug benefits for multiple sclerosis provided by the insurer.  This section shall also require coverage for such an ongoing disease-modifying prescription drug treatment for multiple sclerosis under any non-group policy.

SECTION 5. Chapter 176G of the General Laws, as appearing in the 2014 Official Edition,  is hereby amended by inserting after Section 4AA the following new section:-

Section 4BB.  An individual or group health maintenance contract shall provide coverage and benefits to any individual within the commonwealth for a disease-modifying prescription drug for treatment of multiple sclerosis that the individual has already been prescribed and has already been taking.  The benefits in this section shall not be subject to any greater deductible, coinsurance, copayments or out-of-pocket limits than any other benefits provided by the insurer for disease-modifying prescription drugs to treat multiple sclerosis.  This section shall also require coverage for such an ongoing disease-modifying prescription drug treatment for multiple sclerosis under any non-group policy.